CD80 Antibody and MTX Co-Engineered Extracellular Vesicles Targets CD80+ Macrophages to Suppress Inflammation and Alleviate Chronic Inflammatory Diseases

CD80 Antibody and MTX Co-Engineered Extracellular Vesicles Targets CD80+ Macrophages to Suppress Inflammation and Alleviate Chronic Inflammatory Diseases

Jianhua Yang,1,* Handan Zhang,2,* Wenzhe Wang,1,* Qiqi Yin,2,* Xiaoning He,1 Dihao Tao,1 Hanzhe Wang,1 Wenhao Liu,1 Yiming Wang,1 Zhiwei Dong,3 Xin Chen,2 Bei Li1 1State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Na...

Full description

Saved in:
Bibliographic Details
Main Authors: Yang J, Zhang H, Wang W, Yin Q, He X, Tao D, Wang H, Liu W, Wang Y, Dong Z, Chen X, Li B
Format: Article
Language:English
Published: Dove Medical Press 2025-05-01
Series:International Journal of Nanomedicine
Subjects:
anti-CD80-MTX-EVs
macrophages
rheumatoid arthritis
periodontitis
immune tolerance
Treg cells
Online Access:https://www.dovepress.com/cd80-antibody-and-mtx-co-engineered-extracellular-vesicles-targets-cd8-peer-reviewed-fulltext-article-IJN
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.dovepress.com/cd80-antibody-and-mtx-co-engineered-extracellular-vesicles-targets-cd8-peer-reviewed-fulltext-article-IJN

Similar Items